Stemcells (STEM) Posts Q4 Loss of 47c/Share, Wider than Views

Stemcells (NASDAQ: STEM) reported Q4 EPS of ($0.47), $0.11 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $541 thousand versus the consensus estimate of $490 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
• Martin Marietta completes acquisition of Lhoist North America